Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Association of interleukin-6 genetic polymorphisms with risk of OSCC in Indian population.

Singh PK, Chandra G, Bogra J, Gupta R, Kumar V, Jain A, Hussain SR, Mahdi AA, Ahmad MK.

Meta Gene. 2015 May 15;4:142-51. doi: 10.1016/j.mgene.2015.03.002. eCollection 2015 Jun.

2.

IL6 genotype, tumour ER-status, and treatment predicted disease-free survival in a prospective breast cancer cohort.

Markkula A, Simonsson M, Ingvar C, Rose C, Jernström H.

BMC Cancer. 2014 Oct 11;14:759. doi: 10.1186/1471-2407-14-759.

3.

Cyclooxygenase-2 and the inflammogenesis of breast cancer.

Harris RE, Casto BC, Harris ZM.

World J Clin Oncol. 2014 Oct 10;5(4):677-92. doi: 10.5306/wjco.v5.i4.677. Review.

4.

Genetic variants in interleukin genes are associated with breast cancer risk and survival in a genetically admixed population: the Breast Cancer Health Disparities Study.

Slattery ML, Herrick JS, Torres-Mejia G, John EM, Giuliano AR, Hines LM, Stern MC, Baumgartner KB, Presson AP, Wolff RK.

Carcinogenesis. 2014 Aug;35(8):1750-9. doi: 10.1093/carcin/bgu078. Epub 2014 Mar 26.

5.

Dietary intake of folate, B-vitamins and methionine and breast cancer risk among Hispanic and non-Hispanic white women.

Yang D, Baumgartner RN, Slattery ML, Wang C, Giuliano AR, Murtaugh MA, Risendal BC, Byers T, Baumgartner KB.

PLoS One. 2013;8(2):e54495. doi: 10.1371/journal.pone.0054495. Epub 2013 Feb 11.

6.

Genetic variation in genes involved in hormones, inflammation and energetic factors and breast cancer risk in an admixed population.

Slattery ML, John EM, Torres-Mejia G, Lundgreen A, Herrick JS, Baumgartner KB, Hines LM, Stern MC, Wolff RK.

Carcinogenesis. 2012 Aug;33(8):1512-21. doi: 10.1093/carcin/bgs163. Epub 2012 May 4.

7.

Fatigue and sleep quality are associated with changes in inflammatory markers in breast cancer patients undergoing chemotherapy.

Liu L, Mills PJ, Rissling M, Fiorentino L, Natarajan L, Dimsdale JE, Sadler GR, Parker BA, Ancoli-Israel S.

Brain Behav Immun. 2012 Jul;26(5):706-13. doi: 10.1016/j.bbi.2012.02.001. Epub 2012 Mar 2.

8.

Obesity, inflammation, and postmenopausal breast cancer: therapeutic implications.

Macciò A, Madeddu C.

ScientificWorldJournal. 2011;11:2020-36. doi: 10.1100/2011/806787. Epub 2011 Oct 27. Review.

9.

Cumulative inflammatory load is associated with short leukocyte telomere length in the Health, Aging and Body Composition Study.

O'Donovan A, Pantell MS, Puterman E, Dhabhar FS, Blackburn EH, Yaffe K, Cawthon RM, Opresko PL, Hsueh WC, Satterfield S, Newman AB, Ayonayon HN, Rubin SM, Harris TB, Epel ES; Health Aging and Body Composition Study.

PLoS One. 2011;6(5):e19687. doi: 10.1371/journal.pone.0019687. Epub 2011 May 13.

10.

Breast cancer in Latinas: gene expression, differential response to treatments, and differential toxicities in Latinas compared with other population groups.

Patel TA, Colon-Otero G, Bueno Hume C, Copland JA 3rd, Perez EA.

Oncologist. 2010;15(5):466-75. doi: 10.1634/theoncologist.2010-0004. Epub 2010 Apr 28. Review.

11.

Prescriptions for selective cyclooxygenase-2 inhibitors, non-selective non-steroidal anti-inflammatory drugs, and risk of breast cancer in a population-based case-control study.

Cronin-Fenton DP, Pedersen L, Lash TL, Friis S, Baron JA, Sørensen HT.

Breast Cancer Res. 2010;12(2):R15. doi: 10.1186/bcr2482. Epub 2010 Mar 1.

12.

PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3).

Dossus L, Kaaks R, Canzian F, Albanes D, Berndt SI, Boeing H, Buring J, Chanock SJ, Clavel-Chapelon F, Feigelson HS, Gaziano JM, Giovannucci E, Gonzalez C, Haiman CA, Hallmans G, Hankinson SE, Hayes RB, Henderson BE, Hoover RN, Hunter DJ, Khaw KT, Kolonel LN, Kraft P, Ma J, Le Marchand L, Lund E, Peeters PH, Stampfer M, Stram DO, Thomas G, Thun MJ, Tjonneland A, Trichopoulos D, Tumino R, Riboli E, Virtamo J, Weinstein SJ, Yeager M, Ziegler RG, Cox DG.

Carcinogenesis. 2010 Mar;31(3):455-61. doi: 10.1093/carcin/bgp307. Epub 2009 Dec 4.

13.

Convergence of hormones, inflammation, and energy-related factors: a novel pathway of cancer etiology.

Slattery ML, Fitzpatrick FA.

Cancer Prev Res (Phila). 2009 Nov;2(11):922-30. doi: 10.1158/1940-6207.CAPR-08-0191. Review.

14.

Tumor markers and rectal cancer: support for an inflammation-related pathway.

Slattery ML, Wolff RK, Herrick J, Caan BJ, Samowitz W.

Int J Cancer. 2009 Oct 1;125(7):1698-704. doi: 10.1002/ijc.24467.

15.

Host genetic variants in the interleukin-6 promoter predict poor outcome in patients with estrogen receptor-positive, node-positive breast cancer.

DeMichele A, Gray R, Horn M, Chen J, Aplenc R, Vaughan WP, Tallman MS.

Cancer Res. 2009 May 15;69(10):4184-91. doi: 10.1158/0008-5472.CAN-08-2989. Epub 2009 May 12.

16.

Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and risk of breast cancer among premenopausal women in the Nurses' Health Study II.

Eliassen AH, Chen WY, Spiegelman D, Willett WC, Hunter DJ, Hankinson SE.

Arch Intern Med. 2009 Jan 26;169(2):115-21; discussion 121. doi: 10.1001/archinternmed.2008.537.

17.

Colon tumor mutations and epigenetic changes associated with genetic polymorphism: insight into disease pathways.

Slattery ML, Wolff RK, Curtin K, Fitzpatrick F, Herrick J, Potter JD, Caan BJ, Samowitz WS.

Mutat Res. 2009 Jan 15;660(1-2):12-21. doi: 10.1016/j.mrfmmm.2008.10.001. Epub 2008 Oct 15.

18.

Nonsteroidal anti-inflammatory drugs and change in mammographic density: a cohort study using pharmacy records on over 29,000 postmenopausal women.

Terry MB, Buist DS, Trentham-Dietz A, James-Todd TM, Liao Y.

Cancer Epidemiol Biomarkers Prev. 2008 May;17(5):1088-95. doi: 10.1158/1055-9965.EPI-07-2836.

19.

Modifying effects of IL-6 polymorphisms on body size-associated breast cancer risk.

Slattery ML, Curtin K, Sweeney C, Wolff RK, Baumgartner RN, Baumgartner KB, Giuliano AR, Byers T.

Obesity (Silver Spring). 2008 Feb;16(2):339-47. doi: 10.1038/oby.2007.44.

20.

IL6 genotypes and colon and rectal cancer.

Slattery ML, Wolff RK, Herrick JS, Caan BJ, Potter JD.

Cancer Causes Control. 2007 Dec;18(10):1095-105. Epub 2007 Aug 13.

Items per page

Supplemental Content

Write to the Help Desk